-
1Academic Journal
Συγγραφείς: N. G. Uskova, D. G. Akhaladze, N. S. Grachev, Н. Г. Ускова, Д. Г. Ахаладзе, Н. С. Грачев
Πηγή: Russian Journal of Pediatric Hematology and Oncology; Том 12, № 1 (2025); 48-54 ; Российский журнал детской гематологии и онкологии (РЖДГиО); Том 12, № 1 (2025); 48-54 ; 2413-5496 ; 2311-1267
Θεματικοί όροι: подростки, malignant tumors, neuroendocrine lung tumor, lung carcinoid, lung cancer, pleuropulmonary blastoma, children, adolescents, злокачественные опухоли, нейроэндокринная опухоль легкого, карциноид легкого, рак легкого, плевропульмональная бластома, дети
Περιγραφή αρχείου: application/pdf
Relation: https://journal.nodgo.org/jour/article/view/1130/985; Hartman G.E., Shochat S.J. Primary pulmonary neoplasms of childhood: a review. Ann Thorac Surg. 1983;36(1):108–19. doi:10.1016/s0003-4975(10)60664-9.; Cohen M.C., Kaschula R.O. Primary pulmonary tumors in childhood: a review of 31 years’ experience and the literature. Pediatr Pulmonol. 1992;14(4):222–32. doi:10.1002/ppul.1950140405.; Dishop M.K., Kuruvilla S. Primary and metastatic lung tumors in the pediatric population: a review and 25-year experience at a large children’s hospital. Arch Pathol Lab Med. 2008;132(7):1079–103. doi:10.5858/2008-132-1079-PAMLTI.; An J., Han J., Ahn K.H., Kim J., Choi Y.S. Primary neoplasms of the lung in children and adolescents: 22 cases from a single institute. J Lung Cancer. 2009;8(2):103–10. doi:10.6058/jlc.2009.8.2.103.; Weldon C.B., Shamberger M.D. Pediatric pulmonary tumors: primary and metastatic. Semin Pediatr Surg. 2008;17:17–29. doi:10.1053/j.sempedsurg.2007.10.004.; Yu D.C., Grabowski M.J., Kozakewich H.P., Perez-Atayde A.R., Voss S.D., Shamberger R.C., Weldon C.B. Primary lung tumors in children and adolescents: a 90-year experience. J Pediatr Surg. 2010;45:1090–5. doi:10.1016/j.jpedsurg.2010.02.070.; Indolfi P., Casale F., Carli M., Bisobno G., Ninfo V., Cecchetto G., Bagnulo S., Santoro N., Giuliano M., Di Tullio M.T. Pleuropulmonary blastoma: management and prognosis of 11 cases. Cancer. 2000;89:1396–401. doi:10.1002/1097-0142(20000915)89:63.0.CO;2-2.; Dehner L.P., Tazelaar H.D., Manabe T. Pleuropulmonary blastoma. In: World Health Organization classifi cation of tumours. Pathology and genetics of tumours of the lung, pleura, thymus and heart. Travis W.D., Brambilla E., Muller-Hermelink H.K., Harris C.C. (eds.). IARC Press, Lyon, 2004. Pp. 99–100.; Büyükavc M., Altas S., Salman B., Eren S. An aggressive childhood tumor mimicking pleural empyema: pleuropulmonary blastoma. J Pediatr Hematol Oncol. 2006;28(4):257–9. doi:10.1097/01.mph.0000212917.24051.6f.; Neville H.L., Hogan A.R., Zhuge Y., Perez E.A., Cheung M.C., Koniaris L.G., Thompson W.R., Sola J.E. Incidence and outcomes of malignant pediatric neoplasms. J Surg Res. 2009;156(2):224–30. doi:10.1016/j.jss.2009.03.100.; Abele M., Voggel S., Bremensdorfer C., Spix C., Erdmann F., Kuhlen M., Redlich A., Ebinger M., Lang P., Schneider D.T., Brecht I.B. Incidences and characteristics of primary lung malignancies in childhood in Germany: An analysis of population-based data from German cancer registries. Pediatr Blood Cancer. 2022;69(9):e29744. doi:10.1002/pbc.29744.; Ferrari A., Brecht I.B., Gatta G., Schneider D.T., Orbach D., Cecchetto G., Godzinski J., Reguerre Y., Bien E., Stachowicz-Stencel T., Ost M., Magni C., Kearns P., Vassal G., Massimino M., Biondi A., Bisogno G., Trama A. Defi ning and listing very rare cancers of paediatric age: consensus of the Joint Action on Rare Cancers in cooperation with the European Cooperative Study Group for Pediatric Rare Tumors. Eur J Cancer. 2019;110:120–6. doi:10.1016/j.ejca.2018.12.031.; Rojas Y., Shi Y.X., Zhang W., Beierle E.A., Doski J.J., Goldfarb M., Goldin A.B., Gow K.W., Langer M., Vasudevan S.A., Nuchtern J.G. Primary malignant pulmonary tumors in children: a review of the national cancer data base. J Pediatr Surg. 2015;50(6):1004–8. doi:10.1016/j.jpedsurg.2015.03.032.; Smith N.J., Mukherjee D., Wang Y., Brazauskas R., Nelson A.A., Cortina C.S. Epidemiology and outcomes of primary pediatric lung malignancies: Updates from the SEER database. Am J Surg. 2021;222(4):861–6. doi:10.1016/j.amjsurg.2021.01.037.; Demir H.A., Yalcin B., Ciftci A.O., Ciftci A.O., Orhan D., Varan A., Akyuz C., Kutluk T., Buyukpamukcu M. Primary pleuropulmonary neoplasms in childhood: fourteen cases from a single center. Asian Pac J Cancer Prev. 2011;12(2):543–7. PMID: 21545227.; Erdmann F., Kaatsch P., Grabow D., Spix C. German Childhood Cancer Registry – Annual Report 2019 (1980–2018). Institute of medical biostatistics, epidemiology and informatics (IMBEI) at the University Medical Center of the Johannes Gutenberg University Mainz. 2020;28.; Youlden D.R., Foresto S.A., Aitken J.F. Primary malignant lung tumors in children: a report from the Australian Childhood Cancer Registry, 1983–2015. Pediatr Pulmonol. 2020;55(3):719–22. doi:10.1002/ppul.24636.; Hancock B.J., DiLorenzo M., Youssef S., Yazbeck S., Marcotte J.E., Collin P.P. Childhood primary pulmonary neoplasms. J Pediatr Surg. 1993;28:1133–6. doi:10.1016/0022-3468(93)90147-d.; McCahon E. Lung tumours in children. Paediatr Respir Rev. 2006;7:191–6. doi:10.1016/j.prrv.2006.05.002.; Lal D.R., Clark I., Shalkow J., Downey R.J., Shorter N.A., Klimstra D.S., La Quaglia M.P. Primary epithelial lung malignancies in the pediatric population. Pediatr Blood Cancer. 2005;45:683–6. doi:10.1002/pbc.20279.; Wang L.T., Wilkins E.W., Bode H.H. Bronchial carcinoid tumors in pediatric patients. Chest. 1993;103(5):1426–8. doi:10.1378/chest.103.5.1426.; Moraes T.J., Langer J.C., Forte V., Shayan K., Sweezey N. Pediatric pulmonary carcinoid: a case report and review of the literature. Pediatr Pulmonol. 2003;35:318–22. doi:10.1002/ppul.10249.; Faurox B., Aynie V., Larroquet M., Boccon-Gibod L., Ducou le Pointe H., Tamalet A., Clement A. Carcinoid and mucoepidermoid bronchial tumors in children. Eur J Pediatr. 2005;164:748–52. doi:10.1007/s00431-005-1740-x.; Welsh J.H., Maxson T., Jaksic I., Shahab I., Hicks J. Tracheobroncial mucoepidermoid carcinoma in childhood and adolescence: a case report and review of the literature. Int J Pediatr Otorhinolaryngol. 1998;45:265–73. doi:10.1016/s0165-5876(98)00120-7.; Ramos S.G., Barbosa G.H., Tavora F.R., Jeudy J., Torres L.A.G.M., Tone L.G., Trad C.S. Bronchoalveolar carcinoma arising in a congenial pulmonary airway malformation in a child: case report with an update of this asso ciation. J Pediatr Surg. 2007;42:E1–4. doi:10.1016/j.jpedsurg.2007.02.003.; West D., Nicholson A.G., Colquhoun I., Pollock J. Bronchoalveolar carcinoma in congenital cyst adenomatoid malformation of lung. Ann Thorac Surg. 2007;83:687–9. doi:10.1016/j.athoracsur.2006.06.029.; Bartley T.D., Arean V.M. Intrapulmonary neurogenic tumors. J Thorac Cardiovasc Surg. 1965;50:114–23. PMID: 14313860.; Crist W.M., Raney R.B. Jr, Newton W., Lawrence W. Jr, Teff t M., Foulkes M.A. Intrathoracic soft tissue sarcomas in children. Cancer. 1982;50(3):598–604. doi:10.1002/1097-0142(19820801)50:33.0.co;2-#.; Jimenez J.F., Uthman E.O., Townsend J.W., Gloster E.S., Seibert J.J. Primary bronchopulmonary leiomyosarcoma in childhood. Arch Pathol Lab Med. 1986;110(4):348–51. PMID: 3754125.; Pettinato G., Manivel J.C., Saldana M.J., Peyser J., Dehner L.P. Primary bronchopulmonary fi brosarcoma of childhood and adolescence: reassessment of a low-grade malignancy. Clinicopathologic study of fi ve cases and review of the literature. Hum Pathol. 1989;20(5):463–71. doi:10.1016/0046-8177(89)90012-9.; Muwakkit S.A., Rodriguez-Galindo C., El Samra A.I., Khoury R., Akel S.R., Mroueh S., Razzouk B., Abboud M.R. Primary malignant peripheral nerve sheath tumor of the lung in a young child without neurofi bromatosis type 1. Pediatr Blood Cancer. 2006;47(5):636–8. doi:10.1002/pbc.20787.; Ferrari A., Bisogno G., Alaggio R., Cecchetto G., Collini P., Rosolsen A., Meazza C., Indolfi P., Garaventa A., De Sio L., D’Angelo P., Tamaro P., Casanova M., Carli M. Synovial sarcoma of children and adolescents: the prognostic role of axial sites. Eur J Cancer. 2008;44(9):1202–9. doi:10.1016/j.ejca.2008.03.016.; Balaji R., Kumar P., Garg I., Das K. Primary pulmonary rhabdomyosarcoma in a child. J Indian Assoc Pediatr Surg. 2017;22(1):57–9. doi:10.4103/0971-9261.194629.; Wu X., Zhou C., Jin L., Liu H., Liu J., Zhao S. Primary pulmonary lymphoma in children. Orphanet J Rare Dis. 2019;14(1):35. doi:10.1186/s13023-019-1009-5.; Oguz B., Ozcan H.N., Omay B., Ozgen B., Haliloglu M. Imaging of childhood infl ammatory myofi broblastic tumor. Pediatr Radiol. 2015;45(11):1672–81. doi:10.1007/s00247-015-3377-x.; Travis W.D., Brambilla E., Nicholson A.G., Yatabe Y., Austin J.H.M., Beasley M.B., Chirieac L.R., Dacic S., Duhig E., Flieder D.B., Geisinger K., Hirsch F.H., Ishikawa Y., Kerr K.M., Noguchi M., Pelosi G., Powell C.A., Sound Tsao M., Wistuba I., WHO panel. The 2015 World Health Organization classifi cation of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classifi cation. J Thorac Oncol. 2015;10(9):1243–60. doi:10.1097/JTO.0000000000000630.; Messinger Y.H., Stewart D.R., Priest J.R., Williams G.M., Harris A.K., Schultz K.A.P., Yang J., Doros L., Rosenberg P.S., Hill D.A., Dehner L.P. Pleuropulmonary blastoma: a report on 350 central pathology-confi rmed pleuropulmonary blastoma cases by the International Pleuropulmonary Blastoma Registry. Cancer. 2015;121(2):276–85. doi:10.1002/cncr.29032.; Gelinas J.F., Manoukian J., Cote A. Lung involvement in juvenile onset recurrent respiratory papillomatosis: a systematic review of the literature. Int J Pediatr Otorhinolaryngol. 2008;72(4):433–52. doi:10.1016/j.ijporl.2007.12.003.; Casagrande A., Pederiva F. Association between congenital lung malformations and lung tumors in children and adults: a systematic review. J Thorac Oncol. 2016;11(11):1837–45. doi:10.1016/j.jtho.2016.06.023.; Karatayli-Ozgursoy S., Bishop J.A., Hillel A., Akst L., Best S.R. Risk factors for dysplasia in recurrent respiratory papillomatosis in an adult and pediatric population. Ann Otol Rhinol Laryngol. 2016;125(3):235–41. doi:10.1177/0003489415608196.; Mai P.L., Best A.F., Peters J.A., DeCastro R.M., Khincha P.P., Loud J.T., Bremer R.C., Rosenberg P.S., Savage S.A. Risks of fi rst and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li–Fraumeni syndrome cohort. Cancer. 2016;122(23):3673–81. doi:10.1002/cncr.30248.; Niitu Y., Kubota H., Hasegawa S., Horikawa M., Komatsu S. Lung cancer (squamous cell carcinoma) in adolescence. Am J Dis Child. 1974;127:108–11. doi:10.1001/archpedi.1974.02110200110017.; La Salle A.J., Andrassy R.J., Stanfor W. Bronchogenic squamous cell carcinoma in childhood: a case report. J Pediatr Surg. 1977;12:519–21. doi:10.1016/0022-3468(77)90189-0.; Sharma R., Stein D., Khan W. Primary squamous cell carcinoma of the lung in a 7-year old boy: a case report. J Pediatr Hematol Oncol. 2011;33:e307–9. doi:10.1097/MPH.0b013e31822bf5e2.; Longhi A., Bertoni F., Bacchini P., Albisinni U., Mercati U., Bacci G. Simultaneous osteosarcoma lung metastasis and second primary lung cancer. J Pediatr Hematol Oncol. 2004;26(7):457–61. doi:10.1097/00043426-200407000-00013.; Holmqvist A.S., Chen Y., Berano Teh J.B., Sun C., Birch J.M., van des Bos C., Diller L.R., Dilley K., Ginsberg J., Martin L.T., Nagarajan R., Nathan P.C., Neglia J.P., Terenziani M., Tishler D., Meadows A.T., Robinson L.L., Oberlin O., Bhatia S. Risk of solid subsequent malignant neoplasms after childhood Hodgkin lymphoma identifi cation of high-risk populations to guide surveillance: a report from the Late Eff ects Study Group. Cancer. 2019;125(8):1373–83. doi:10.1002/cncr.31807.; Giuseppucci C., Reusmann A., Giubergia V., Barrias C., Kruger A., Siminovich M., Botto H., Cadario M., Boglione M., Srtambach J., Barrenechea M. Primary lung tumors in children: 24 years of experience at a referral center. Pediatr Surg Int. 2016;32:451–7. doi:10.1007/s00383-016-3884-3.; Lichtenberger J.P., Biko D.M., Carter B.W., Pavio M.A., Huppmann A.R., Chung E.M. Primary lung tumors in children: radiologic-pathology correlation. Radiographics. 2018;38(7):2151–72. doi:10.1148/rg.2018180192.; Dahabreh J., Stathopouls G.P., Koutantos J., Rigatos S. Lung carcinoid tumor biology: treatment and survival. Oncol Rep. 2009;21:757–60. doi:10.3892/or_00000281.; Rizzardi G.G., Marulli L., Bortolotti F., Calabrese F., Sartori F., Rea F. Sleeve resections and bronchoplastic procedures in typical central carcinoid tumors. Thorac Cardiovasc Surg. 2008;56:42–5. doi:10.1055/s-2007-965741.; Kanemoto A., Oshiro Y., Sugahara S., Kamagata S., Hirobe S., Toma M., Okumura T., Sakurai H. Proton beam therapy for inoperable recurrence of bronchial high-grade mucoepidermoid carcinoma. Jpn J Clin Oncol. 2012;42:552–5. doi:10.1093/jjco/hys047.; Rizzardi G., Maruli G., Calabrese F., Rugge M., Rebusso A., Sartori F., Rea F. Bronchial carcinoid tumours in children: surgical treatment and outcome in a single institution. Eur J Pediatr Surg. 2009;19:228–31. doi:10.1055/s-0029-1202857.; Marty-Ane C.H., Costes V., Pujol J.L., Alauzen M., Baldet P., Mary H. Carcinoid tumors of the lung: do atypical features require aggressive management? Ann Thorac Surg. 1995;59(1):78–83. doi:10.1016/0003-4975(94)00630-P.; Manchua T.N., Guerreiro-Cardoso P.F., Camargo S.M., Signori L., Andrade C.F., Schneider Moreira A.L., da Silva Moreira J., Felicetti J.C., Camargo J.J. Surgical treatment of bronchial carcinoid tumors: a single-center experience. Lung Canc. 2010;70:158–62. doi:10.1016/j.lungcan.2010.01.015.; Daddi N., Schiavon M., Filosso P.L., Cardillo G., Ambrogi M.C., De Palma A., Luzzi L., Bandiera A., Casali C., Ruff ato A., De Angelis V., Andriolo L.G., Guerrera F., Carleo F., Davini F., Urbani M., Mattioli S., Zannini P., Gotti G., Loizzi M., Puma F., Mussi A., Ricci A., Oliaro A., Rea F. Prognostic factors in a multicenter study of 247 atypical pulmonary carcinoids. Eur J Cardiothorac Surg. 2014;45:677–86. doi:10.1093/ejcts/ezt470.; Degnan A.J., Tocchio S., Kurtom W., Tadros S.S. Pediatric neuroendocrine carcinoid tumors: management, pathology, and imaging fi ndings in a pediatric referral center. Pediatr Blood Canc. 2017;64:264–77. doi:10.1002/pbc.26477.; Rizzardi G., Bertolaccini L., Terzi A. Bronchial carcinoid tumours in children – a review. Eur J Haematol. 2011;7(3):196–9. doi:10.17925/EOH.2011.07.03.196.; Balzer B.W.R., Loo C., Lewis C.R., Trahair T.N., Anazodo A.C. Adenocarcinoma of the lung in childhood and adolescence: a systematic review. J Thorac Oncol. 2018;13(12):1832–41. doi:10.1016/j.jtho.2018.08.2020.; Chin C.H., Huang C.C., Lin M.C., Chao T.Y., Liu S.F. Prognostic factors of tracheobronchial mucoepidermoid carcinoma – 15 years experience. Respirology. 2008;13:275–80. doi:10.1111/j.1440-1843.2007.01207.x.; Ferguson M.K., Landreneau R.J., Hazelrigg S.R., Altorki N.K., Naunheim K.S., Zwischenberger J.B., Kent M., Yim A.P. Long-term outcome after resection for bronchial carcinoid tumors. Eur J Cardiothorac Surg. 2000;18(2):156–61. doi:10.1016/s1010-7940(00)00493-0.; Techavichit P., Hicks M.J., Lopez-Terrada D.H., Quintanilla N.M., Guillerman R.P., Sarabia S.F., Sayeed J.G., Paulino A.C., Muscal J.A., Okcu M.F., Chintagumpala M. Mucoepidermoid carcinoma in children: a single institutional experience. Pediatr Blood Cancer. 2016;63(1):27–31. doi:10.1002/pbc.25681.; Grigoletto V., Tagarelli A., Atzeni C., Cecchetto G., Indolfi P., De Pasquale M.D., De Leonardis F., Coppadoro B., Sorbara S., Chiaravalli S., Ferrari A., Bisogno G. Pleuropulmonary blastoma: a report from the TREP (Tumori Rari in Eta Pediatrica) Project. Tumori. 2020;106(2):126–32. doi:10.1177/0300891619871344.; https://journal.nodgo.org/jour/article/view/1130
-
2Academic Journal
Συγγραφείς: Grineva E.N., Tsoy U.A., Ryzhkova D.V.
Συνεισφορές: 0
Πηγή: Annals of the Russian academy of medical sciences; Vol 79, No 1 (2024); 77-86 ; Вестник Российской академии медицинских наук; Vol 79, No 1 (2024); 77-86 ; 2414-3545 ; 0869-6047 ; 10.15690/vramn.11
Θεματικοί όροι: neuroendocrine tumors, hypercortisolism, ectopic ACTH syndrome, functional imaging, нейроэндокринная опухоль, гиперкортицизм, эктопический АКТГ-синдром, функциональная визуализация
Περιγραφή αρχείου: application/pdf
Relation: https://vestnikramn.spr-journal.ru/jour/article/view/12677/1925; https://vestnikramn.spr-journal.ru/jour/article/view/12677/1896; https://vestnikramn.spr-journal.ru/jour/article/downloadSuppFile/12677/103163; https://vestnikramn.spr-journal.ru/jour/article/downloadSuppFile/12677/111986; https://vestnikramn.spr-journal.ru/jour/article/downloadSuppFile/12677/145559
-
3Academic Journal
Συγγραφείς: Kolyago O.O., Munirova A.A., Ivanov S.V., Stilidi I.S.
Συνεισφορές: 1
Πηγή: Almanac of Clinical Medicine; Vol 52, No 3 (2024); 178-187 ; Альманах клинической медицины; Vol 52, No 3 (2024); 178-187 ; 2587-9294 ; 2072-0505
Θεματικοί όροι: depression, anxiety disorders, neuroendocrine tumor, mental disorders, serotonin, депрессия, тревожные расстройства, нейроэндокринная опухоль, психические расстройства
Περιγραφή αρχείου: application/pdf
Relation: https://almclinmed.ru/jour/article/view/17240/1659; https://almclinmed.ru/jour/article/view/17240/1676; https://almclinmed.ru/jour/article/downloadSuppFile/17240/160000; https://almclinmed.ru/jour/article/downloadSuppFile/17240/160001; https://almclinmed.ru/jour/article/view/17240
-
4Academic Journal
Συγγραφείς: Kvachenyuk, A.M., Kvachenyuk, D.A.
Πηγή: Mìžnarodnij Endokrinologìčnij Žurnal, Vol 16, Iss 1, Pp 44-49 (2020)
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine); Том 16, № 1 (2020); 44-49
Международный эндокринологический журнал-Mìžnarodnij endokrinologìčnij žurnal; Том 16, № 1 (2020); 44-49
Міжнародний ендокринологічний журнал-Mìžnarodnij endokrinologìčnij žurnal; Том 16, № 1 (2020); 44-49Θεματικοί όροι: carcinoid, apud-system, review, carcinoid syndrome, нейроендокринна пухлина, карциноїд, APUD-система, хромогранін А, карциноїдний синдром, огляд, RC648-665, Diseases of the endocrine glands. Clinical endocrinology, 3. Good health, 03 medical and health sciences, 0302 clinical medicine, neuroendocrine tumor, APUD-system, chromogranin А, chromogranin а, нейроэндокринная опухоль, карциноид, хромогранин А, карциноидный синдром, обзор
Περιγραφή αρχείου: application/pdf
-
5Report
Θεματικοί όροι: иммуногистохимическое исследование, СППО, нейроэндокринная опухоль, endosonography, поджелудочная железа, immunohistochemical study, solid pseudopapillary neoplasm, cytological diagnostics, цитологическая диагностика, SPN, NET, НЭО, тонкоигольная аспирационная биопсия, fine-needle aspiration biopsy, эндосонография, pancreas, солидно-псевдопапиллярная опухоль, иммуноцитохимическое исследование, immunocytochemical study, neuroendocrine tumor
-
6
-
7Academic Journal
-
8Academic Journal
Συγγραφείς: Lotova, V. S., Pashaeva, N. V., Zhdanova, I. V., Kuznetsova, E. V., Лотова, В. С., Пашаева, Н. В., Жданова, И. В., Кузнецова, Е. В.
Πηγή: Сборник статей
Θεματικοί όροι: ACTH-ECTOPIC SYNDROME, PANCREATIC NEUROENDOCRINE TUMOR, АКТГ-ЭКТОПИРОВАННЫЙ СИНДРОМ, НЕЙРОЭНДОКРИННАЯ ОПУХОЛЬ ПОДЖЕЛУДОЧНОЙ ЖЕЛЕЗЫ
Περιγραφή αρχείου: application/pdf
Relation: Актуальные вопросы современной медицинской науки и здравоохранения: сборник статей VIII Международной научно-практической конференции молодых учёных и студентов, Екатеринбург, 19-20 апреля 2023 г.; http://elib.usma.ru/handle/usma/13394
Διαθεσιμότητα: http://elib.usma.ru/handle/usma/13394
-
9Academic Journal
Συγγραφείς: E. S. Drozdov, M. Yu. Grishchenko, V. I. Kharitonkin, N. I. Lyan, O. Yu. Borodin, E. A. Fesik, A. G. Korotkevich, Е. С. Дроздов, М. Ю. Грищенко, В. И. Харитонкин, Н. И. Лян, О. Ю. Бородин, Е. А. Фесик, А. Г. Короткевич
Πηγή: Siberian journal of oncology; Том 22, № 2 (2023); 168-174 ; Сибирский онкологический журнал; Том 22, № 2 (2023); 168-174 ; 2312-3168 ; 1814-4861
Θεματικοί όροι: иммуногистохимия, Ampulla of Vater, neuroendocrine tumor, clinical case, immunohistochemistry, большой дуоденальный сосок, нейроэндокринная опухоль
Περιγραφή αρχείου: application/pdf
Relation: https://www.siboncoj.ru/jour/article/view/2546/1106; Lepage C., Bouvier A.M., Faivre J. Endocrine tumours: epidemiology of malignant digestive neuroendocrine tumours. Eur J Endocrinol. 2013; 168(4): 77–83. doi:10.1530/EJE-12-0418.; Kim J.Y., Hong S.M., Ro J.Y. Recent updates on grading and classifcation of neuroendocrine tumors. Ann Diagn Pathol. 2017; 29: 11–6. doi:10.1016/j.anndiagpath.2017.04.005.; Holmager P., Langer S.W., Kjaer A., Ringholm L., Garbyal R.S., Pommergaard H.C., Hansen C.P., Federspiel B., Andreassen M., Knigge U. Surgery in Patients with Gastro-Entero-Pancreatic Neuroendocrine Carcinomas, Neuroendocrine Tumors G3 and High Grade Mixed Neuroendocrine-Non-Neuroendocrine Neoplasms. Curr Treat Options Oncol. 2022; 23(6): 806–17. doi:10.1007/s11864-022-00969-x.; La Rosa S. Challenges in High-grade Neuroendocrine Neoplasms and Mixed Neuroendocrine/Non-neuroendocrine Neoplasms. Endocr Pathol. 2021; 32(2): 245–57. doi:10.1007/s12022-021-09676-z.; Ren X., Jiang H., Sun K., Qin X., Qu Y., Xia T., Chen Y. Mixed neuroendocrine-non-neuroendocrine neoplasm of the gallbladder: case report and literature review. Diagn Pathol. 2022; 17(1): 51. doi:10.1186/s13000-022-01231-6.; Добродеев А.Ю., Гороховская В.И., Костромицкий Д.Н., Афанасьев С.Г., Бондарь Л.Н., Авдеенко Т.В., Тарасова А.С., Августинович А.В. Смешанная нейроэндокринная-не-нейроэндокринная опухоль толстой кишки: Редкое клиническое наблюдение. Экспериментальная и клиническая гастроэнтерология. 2021; 11(195): 97–99. doi:10.31146/1682-8658-ecg-195-11-97-99.; Zhang L., DeMay R.M. Cytological features of mixed adenoneuroendocrine carcinoma of the ampulla: two case reports with review of literature. Diagn Cytopathol. 2014; 42(12): 1075–84. doi:10.1002/dc.23107.; de Mestier L., Cros J., Neuzillet C., Hentic O., Egal A., Muller N., Bouché O., Cadiot G., Ruszniewski P., Couvelard A., Hammel P. Digestive System Mixed Neuroendocrine-Non-Neuroendocrine Neoplasms. Neuroendocrinology. 2017; 105(4): 412–25. doi:10.1159/000475527.; Minaya-Bravo A.M., Garcia Mahillo J.C., Mendoza Moreno F., Noguelares Fraguas F., Granell J. Large cell neuroendocrine – Adenocarcinona mixed tumour of colon: Collision tumour with peculiar behaviour. What do we know about these tumours? Ann Med Surg (Lond). 2015; 4(4): 399–403. doi:10.1016/j.amsu.2015.10.004.; Frizziero M., Chakrabarty B., Nagy B., Lamarca A., Hubner R.A., Valle J.W., McNamara M.G. Mixed Neuroendocrine Non-Neuroendocrine Neoplasms: A Systematic Review of a Controversial and Underestimated Diagnosis. J Clin Med. 2020; 9(1): 273. doi:10.3390/jcm9010273.; https://www.siboncoj.ru/jour/article/view/2546
-
10Academic Journal
Συγγραφείς: S. A. Buryakina, M. Yu. Pikunov, N. V. Tarbaeva, Zh. E. Belaya, G. G. Karmazanovsky, N. G. Mokrysheva, С. А. Бурякина, М. Ю. Пикунов, Н. В. Тарбаева, Ж. Е. Белая, Г. Г. Кармазановский, Н. Г. Мокрышева
Συνεισφορές: Исследование выполнено при финансовом обеспечении НМИЦ эндокринологии Минздрава России.
Πηγή: Medical Visualization; Том 27, № 4 (2023); 92-103 ; Медицинская визуализация; Том 27, № 4 (2023); 92-103 ; 2408-9516 ; 1607-0763
Θεματικοί όροι: карциноид легкого, CT, neuroendocrine tumor, lung, carcinoid tumor, КТ, нейроэндокринная опухоль
Περιγραφή αρχείου: application/pdf
Relation: https://medvis.vidar.ru/jour/article/view/1353/809; https://medvis.vidar.ru/jour/article/downloadSuppFile/1353/2129; https://medvis.vidar.ru/jour/article/downloadSuppFile/1353/2130; https://medvis.vidar.ru/jour/article/downloadSuppFile/1353/2131; https://medvis.vidar.ru/jour/article/downloadSuppFile/1353/2132; https://medvis.vidar.ru/jour/article/downloadSuppFile/1353/2133; https://medvis.vidar.ru/jour/article/downloadSuppFile/1353/2134; Белая Ж.Е., Рожинская Л.Я., Драгунова Н.В., Дзеранова Л.К., Марова Е.И., Арапова С.Д., Молитвословова Н.Н., Зенкова Т.С., Мельниченко Г.А., Дедов И.И. Метаболические осложнения эндогенного гиперкортицизма. Выбор пациентов для скрининга. Ожирение и метаболизм. 2013; 10 (1): 26–31. http://doi.org/10.14341/2071-8713-5068; Голоунина О.О., Белая Ж.Е., Рожинская Л.Я., Марова Е.И., Пикунов М.Ю., Хандаева П.М., Арапова С.Д., Дзеранова Л.К., Кузнецов Н.С., Фадеев В.В., Мельниченко Г.А., Дедов И.И. Клинико-лабораторная характеристика и результаты лечения пациентов с АКТГ-продуцирующими ней роэндокринными опухолями различной локализации. Терапевтический архив. 2021; 93 (10): 1171–1178. http://doi.org/10.26442/00403660.2021.10.201102; Эндокринология: Национальное руководство / Под ред. И.И. Дедова, Г.А. Мельниченко. М.: ГЭОТАР-Медиа, 2008: 694–702.; Ilias I., Torpy D.J., Pacak K. et al. Cushing’s syndrome due to ectopic corticotropin secretion: twenty years’ experience at the National Institutes of Health. J. Clin. Endocrinol. Metab. 2005; 90 (8): 4955–4962. https://doi.org/10.1210/jc.2004-2527; Голоунина О.О., Белая Ж.Е., Рожинская Л.Я., Пикунов М.Ю., Маркович А.А., Дзеранова Л.К., Марова Е.И., Кузнецов Н.С., Фадеев В.В., Мельниченко Г.А., Дедов И.И. Предикторы выживаемости пациентов c АКТГ-эктопированным синдромом. Проблемы эндокринологии. 2022; 68 (6): 30–42. https://doi.org/10.14341/probl13144; Plotz C.M., Knowlton A.I., Ragan C. The natural history of Сushing's syndrome. Am. J. Med. 1952; 13 (5): 597–614. http://doi.org/10.1016/0002-9343(52)90027-2; Пикунов М.Ю., Печетов А.А., Голоунина О.О., Бурякина С.А., Рожинская Л.Я., Белая Ж.Е. Особенности подготовки и хирургических аспектов лечения пациентов с АКТГ-продуцирующими нейроэндокринными опухолями легких. Эндокринная хирургия. 2021; 15 (2): 4–12. https://doi.org/10.14341/serg12721; Пикунов М.Ю.,Печетов А.А., Есаков Ю.С., Леднев А.Н. Хирургическое лечение пациентки с нейроэндокринной опухолью легкого, ассоциированной с АКТГ-эктопическим синдромом: клинический случай. Эндокринная хирургия. 2018; 12 (2): 5–10.; Utz A., Biller B.M. The role of bilateral inferior petrosal sinus sampling in the diagnosis of Cushing’s syndrome. Arq. Bras. Endocrinol. Metabol. 2007; 51 (8): 1329–1338. http://doi.org/10.1590/s0004-27302007000800019; Кузнецов Н.С., Латкина Н.В., Добрева Е.А. АКТГ-эктопированный синдром: клиника, диагностика, лечение. Эндокринная хирургия. 2012; 1: 24–36; Ситкин И.И., Белая Ж.Е., Рожинская Л.Я., Мельниченко Г.А., Дзеранова Л.К., Марова Е.И., Арапова С.Д., Молитвословова Н.Н., Пигарова Е.А., Григорьев А.Ю., Колесникова Г.С., Воронцов А.В., Дедов И.И. Двухсторонний селективный забор крови из нижних каменистых синусов на фоне стимуляции десмопрессином в дифференциальной диагностике АКТГ-зависимого гиперкортицизма. Диагностическая и интервенционная радиология. 2013; 7 (3): 57–68. https://doi.org/10.25512/DIR.2013.07.3.06; Пикунов М.Ю., Добрева Е.А., Кузнецов Н.С., Латкина Н.В. Нейроэндокринные АКТГ-продуцирующие опухоли легких. Онкология. Журнал им. П.А. Герцена. 2014; 3 (2): 54–58.; Голоунина О.О., Слащук К.Ю., Хайриева А.В., Тарбаева Н.В., Дегтярев М.В., Белая Ж.Е. Лучевая и радионуклидная визуализация в диагностике АКТГ-продуцирующих нейроэндокринных опухолей. Медицинская радиология и радиационная безопасность. 2022; 67 (4): 80–88. http://doi.org/10.33266/1024-6177-2022-67-4-80-88; Serban A.L., Rosso L., Mendogni P. et al. Case Report: A Challenging Localization of a Pulmonary Ectopic ACTH-Secreting Tumor in a Patient With Severe Cushing’s Syndrome. Frontiers in Endocrinology. 2021; 12 (687539): 1–7. http://doi.org/10.3389/fendo.2021.687539; Jain N., Gidwani N. A rare ectopic ACTH secreting atypical pulmonary carcinoid-case report. Trop. J. Path. Micro. 2020; 6 (1): 103–107. http://doi.org/10.17511/jopm.2020.i01.17; Бурякина С.А., Кармазановский Г.Г., Волеводз Н.Н., Пикунов М.Ю., Тарбаева Н.В., Ковалевич Л.Д. КТ-признаки нейроэндокринных опухолей легких и их взаимосвязь с АКТГ-эктопическим синдромом. Российский электронный журнал лучевой диагностики. 2018; 8 (4): 56–72. http://doi.org/10.21569/2222-7415-2018-8-4-56-72; Zwiebel B.R., Austin J.H.M., Grimes M.M. Bronchial carcinoid tumors: assessment with CT location and intratumoral calcification in 31 patients. Radiology. 1991; 179: 483–486. http://doi.org/10.1148/radiology.179.2.2014296; Modlin I.M., Lye K.D., Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer. 2003; 97: 934–959. http://doi.org/10.1002/cncr.11105; Davila D.G., Dunn W.F., Tazelaar H.D., Pairolero P.C. Bronchial carcinoid tumors. Mayo Clin. Proc. 1993; 68: 795–803. http://doi.org/10.1016/s0025-6196(12)60641-7; Forster B.B., Müller N.L., Miller R.R. et al. Neuroendocrine carcinomas of the lung clinical, radiologic, and pathologic correlation. Radiology. 1989; 170: 441–445. http://doi.org/10.1148/radiology.170.2.2536187; Трахтенберг А.Х., Чиссов В.И., Франк Г.А. Нейроэндокринные опухоли легких. М.: Практическая медицина, 2012: 65–76.; Rodrigues P., Castedo J.L., Damasceno M., Carvalho D. Ectopic Cushing's syndrome caused by a pulmonary ACTH-secreting tumor in a patient treated with octreotide. Arq. Bras. Endocrinol Metabol. 2012; 56 (7): 461–464. http://doi.org/10.1093/annonc/mdv041; Caplin M.E., Baudin E., Ferolla P. et al. Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids. Ann. Oncol. 2015; 26 (8): 1604–1620. http://doi.org/10.1093/annonc/mdv041; Meisinger Q.C., Klein J.S., Butnor K.J. et al. CT features of peripheral pulmonary carcinoid tumors. Am. J. Roentgenol. 2011; 197 (5): 1073–1080. http://doi.org/10.2214/AJR.10.5954; https://medvis.vidar.ru/jour/article/view/1353
-
11Academic Journal
Συγγραφείς: E. O. Rodionov, V. A. Stolyarova, S. V. Miller, D. V. Podolko, S. A. Tuzikov, N. V. Bezgodova, A. A. Mokh, V. A. Markovich, D. S. Miller, Е. О. Родионов, В. А. Столярова, С. В. Миллер, Д. В. Подолько, С. А. Тузиков, Н. В. Безгодова, А. А. Мох, В. А. Маркович, Д. С. Миллер
Πηγή: Siberian journal of oncology; Том 21, № 3 (2022); 160-167 ; Сибирский онкологический журнал; Том 21, № 3 (2022); 160-167 ; 2312-3168 ; 1814-4861 ; 10.21294/1814-4861-2022-21-3
Θεματικοί όροι: карциноидное сердце, neuroendocrine biomarkers, small bowel NETs, carcinoid syndrome, carcinoid heart disease, нейроэндокринные биомаркеры, нейроэндокринная опухоль тонкой кишки, карциноидный синдром
Περιγραφή αρχείου: application/pdf
Relation: https://www.siboncoj.ru/jour/article/view/2174/999; Farley H.A., Pommier R.F. Surgical Treatment of Small Bowel Neuroendocrine Tumors. Hematol Oncol Clin North Am. 2016; 30(1): 49–61. doi:10.1016/j.hoc.2015.09.001.; Lee M.R., Harris C., Baeg K.J., Aronson A., Wisnivesky J.P., Kim M.K. Incidence Trends of Gastroenteropancreatic Neuroendocrine Tumors in the United States. Clin Gastroenterol Hepatol. 2019; 17(11): 2212–7. doi:10.1016/j.cgh.2018.12.017.; Barsouk A., Rawla P., Barsouk A., Thandra K.C. Epidemiology of Cancers of the Small Intestine: Trends, Risk Factors, and Prevention. Med Sci (Basel). 2019; 7(3): 46. doi:10.3390/ medsci7030046.; Kalligeros M., Diamantopoulos L., Toumpanakis C. Biomarkers in Small Intestine NETs and Carcinoid Heart Disease: A Comprehensive Review. Biology (Basel). 2021; 10(10): 950. doi:10.3390/biology10100950.; Modlin I.M., Kidd M., Latich I., Zikusoka M.N., Shapiro M.D. Current status of gastrointestinal carcinoids. Gastroenterology. 2005; 128(6): 1717–51. doi:10.1053/j.gastro.2005.03.038.; Clement D., Ramage J., Srirajaskanthan R. Update on Pathophysiology, Treatment, and Complications of Carcinoid Syndrome. J Oncol. 2020. doi:10.1155/2020/8341426.; Орел Н.Ф., Артамонова Е.В., Горбунова В.А., Делекторская В.В., Емельянова Г.С., Любимова Н.В., Маркович А.А., Орлова К.В., Орлова Р.В., Трифанов В.С. Практические рекомендации по лекарственному лечению нейроэндокринных неоплазий желудочно-кишечного тракта, поджелудочной железы и других локализаций. Злокачественные опухоли: Практические рекомендации RUSSCO #3s2. 2021; 11: 499–512; Granberg D. Biochemical Testing in Patients with Neuroendocrine Tumors. Front Horm Res. 2015; 44: 24–39. doi:10.1159/000381981.; Singh S., Asa S.L., Dey C., Kennecke H., Laidley D., Law C., Asmis T., Chan D., Ezzat S., Goodwin R., Mete O., Pasieka J., Rivera J., Wong R., Segelov E., Rayson D. Diagnosis and management of gastrointestinal neuroendocrine tumors: An evidencebased Canadian consensus. Cancer Treat Rev. 2016; 47: 32–45. doi:10.1016/j.ctrv.2016.05.003.; Scott A.T., Howe J.R. Management of Small Bowel Neuroendocrine Tumors. J Oncol Pract. 2018; 14(8): 471–82. doi:10.1200/JOP.18.00135.; Luis S.A., Pellikka P.A. Carcinoid heart disease: Diagnosis and management. Best Pract Res Clin Endocrinol Metab. 2016; 30(1): 149–58. doi:10.1016/j.beem.2015.09.005.; Strosberg J.R., Halfdanarson T.R., Bellizzi A.M., Chan J.A., Dillon J.S., Heaney A.P., Kunz P.L., O'Dorisio T.M., Salem R., Segelov E., Howe J.R., Pommier R.F., Brendtro K., Bashir M.A., Singh S., Soulen M.C., Tang L., Zacks J.S., Yao J.C., Bergsland E.K. The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Midgut Neuroendocrine Tumors. Pancreas. 2017; 46(6): 707–14. doi:10.1097/MPA.0000000000000850.; Howe J.R., Cardona K., Fraker D.L., Kebebew E., Untch B.R., Wang Y.Z., Law C.H., Liu E.H., Kim M.K., Menda Y., Morse B.G., Bergsland E.K., Strosberg J.R., Nakakura E.K., Pommier R.F. The Surgical Management of Small Bowel Neuroendocrine Tumors: Consensus Guidelines of the North American Neuroendocrine Tumor Society. Pancreas. 2017; 46(6): 715–31. doi:10.1097/ MPA.0000000000000846.; Maxwell J.E., Howe J.R. Imaging in neuroendocrine tumors: an update for the clinician. Int J Endocr Oncol. 2015; 2(2): 159–68. doi:10.2217/ije.14.40.; Sundin A., Arnold R., Baudin E., Cwikla J.B., Eriksson B., Fanti S., Fazio N., Giammarile F., Hicks R.J., Kjaer A., Krenning E., Kwekkeboom D., Lombard-Bohas C., O'Connor J.M., O'Toole D., Rockall A., Wiedenmann B., Valle J.W., Vullierme M.P.; Antibes Consensus Conference participants. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine & Hybrid Imaging. Neuroendocrinology. 2017; 105(3): 212–44. doi:10.1159/000471879.; https://www.siboncoj.ru/jour/article/view/2174
-
12Academic Journal
Συγγραφείς: I. S. Gruzdev, G. G. Karmazanovsky, M. G. Lapteva, K. A. Zamyatina, V. S. Tikhonova, E. V. Kondratyev, V. Yu. Struchkov, A. V. Glotov, I. S. Proskuryakov, D. V. Podluzhny, A. Sh. Revishvili, И. С. Груздев, Г. Г. Кармазановский, М. Г. Лаптева, К. А. Замятина, В. С. Тихонова, Е. В. Кондратьев, В. Ю. Стручков, А. В. Глотов, И. С. Проскуряков, Д. В. Подлужный, А. Ш. Ревишвили
Συνεισφορές: The reported study was funded by RFBR, project number 20-315-90070., Исследование выполнено при финансовой поддержке РФФИ в рамках научного проекта № 20-315-90070.
Πηγή: Medical Visualization; Том 26, № 4 (2022); 102-109 ; Медицинская визуализация; Том 26, № 4 (2022); 102-109 ; 2408-9516 ; 1607-0763
Θεματικοί όροι: нейроэндокринная опухоль поджелудочной железы, texture analysis, renal cell carcinoma, metastases, pancreatic neuroendocrine tumor, текстурный анализ, почечно-клеточный рак, метастазы
Περιγραφή αρχείου: application/pdf
Relation: https://medvis.vidar.ru/jour/article/view/1279/765; Ouzaid I., Capitanio U., Staehler M. et al. Surgical Metastasectomy in Renal Cell Carcinoma: A Systematic Review. Eur. Urol. Oncol. 2019; 2 (2): 141–149. https://doi.org/10.1016/J.EUO.2018.08.028; Padala S.A., Barsouk A., Thandra K.C. et al. Epidemiology of Renal Cell Carcinoma. Wld J. Oncol. 2020; 11 (3): 79–87. https://doi.org/10.14740/WJON1279; Shah M.H., Goldner W.S., Benson A.B. et al. Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J. Natl. Compr. Canc. Netw. 2021; 19 (7): 839–867. https://doi.org/10.6004/JNCCN.2021.0032; Campbell S.C., Uzzo R.G., Karam J.A. et al. Renal Mass and Localized Renal Cancer: Evaluation, Management, and Follow-up: AUA Guideline: Part II. J. Urol. 2021; 206 (2): 209–218. https://doi.org/10.1097/JU.0000000000001912; Almeida R.R., Lo G.C., Patino M. et al. Advances in Pancreatic CT Imaging. Am. J. Roentgenol. 2018; 211 (1): 52–66. https://doi.org/10.2214/AJR.17.18665; Lee N.J., Hruban R.H., Fishman E.K. Pancreatic neuroendocrine tumor: review of heterogeneous spectrum of CT appearance. Abdom. Radiol. 2018; 43 (11): 3025–3034. https://doi.org/10.1007/s00261-018-1574-4; Sellner F. Observations on Solitary Versus Multiple Isolated Pancreatic Metastases of Renal Cell Carcinoma: Another Indication of a Seed and Soil Mechanism? Cancers. 2019; 11 (9): 1379. https://doi.org/10.3390/CANCERS11091379; Nogueira M., Dias S.C., Silva A.C. et al. Solitary pancreatic renal cell carcinoma metastasis. Autopsy. Case Reports. 2018; 8 (2): e2018023. https://doi.org/10.4322/ACR.2018.023; Akirov A., Larouche V., Alshehri S. et al. Treatment Options for Pancreatic Neuroendocrine Tumors. Cancers. 2019; 11 (6): 828. https://doi.org/10.3390/CANCERS11060828; Barthet M., Giovannini M., Lesavre N. et al. Endoscopic ultrasound-guided radiofrequency ablation for pancreatic neuroendocrine tumors and pancreatic cystic neoplasms: A prospective multicenter study. Endoscopy. 2019; 51 (9): 836–842. https://doi.org/10.1055/A-0824-7067/ID/JR17031-18; Fazio N., Kulke M., Rosbrook B. et al. Updated Efficacy and Safety Outcomes for Patients with Well-Differentiated Pancreatic Neuroendocrine Tumors Treated with Sunitinib. Target. Oncol. 2021; 16 (1): 27–35. https://doi.org/10.1007/S11523-020-00784-0/FIGURES/4; Quhal F., Mori K., Bruchbacher A. et al. First-line Immunotherapy-based Combinations for Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis. Eur. Urol. Oncol. 2021; 4 (5): 755–765. https://doi.org/10.1016/J.EUO.2021.03.001; Powles T., Albiges L., Bex A. et al. ESMO Clinical Practice Guideline update on the use of immunotherapy in early stage and advanced renal cell carcinoma. Ann. Oncol. 2021; 32 (12): 1511–1519. https://doi.org/10.1016/J.ANNONC.2021.09.014; Gu D., Hu Y., Ding H. et al. CT radiomics may predict the grade of pancreatic neuroendocrine tumors: a multicenter study. Eur. Radiol. 2019; 29 (12): 6880–6890. https://doi.org/10.1007/s00330-019-06176-x; Lin X., Xu L., Wu A. et al. Differentiation of intrapancreatic accessory spleen from small hypervascular neuroendocrine tumor of the pancreas: textural analysis on contrast-enhanced computed tomography. Acta Radiol. 60 (2019) 553–560. https://doi.org/10.1177/0284185118788895; Karmazanovsky G., Gruzdev I., Tikhonova V. et al. Computed tomography-based radiomics approach in pancreatic tumors characterization. Radiol. Medica. 2021; 126: 1388–1395. https://doi.org/10.1007/S11547-021-01405-0/FIGURES/1; van der Pol C.B., Lee S., Tsai S. et al. Differentiation of pancreatic neuroendocrine tumors from pancreas renal cell carcinoma metastases on CT using qualitative and quantitative features. Abdom. Radiol. 2019; 44(3): 992–999. https://doi.org/10.1007/s00261-018-01889-x; Nioche C., Orlhac F., Boughdad S. et al. Lifex: A freeware for radiomic feature calculation in multimodality imaging to accelerate advances in the characterization of tumor heterogeneity. Cancer Res. 2018; 78 (16): 4786–4789. https://doi.org/10.1158/0008-5472.CAN-18-0125; Gruzdev I.S., Zamyatina K.A., Tikhonova V.S. et al. Reproducibility of CT texture features of pancreatic neuroendocrine neoplasms. Eur. J. Radiol. 2020; 133: 109371. https://doi.org/10.1016/j.ejrad.2020.109371; Kang T.W., Kim S.H., Lee J. et al. Differentiation between pancreatic metastases from renal cell carcinoma and hypervascular neuroendocrine tumour: Use of relative percentage washout value and its clinical implication. Eur. J. Radiol. 2015; 84 (11): 2089–2096. https://doi.org/10.1016/J.EJRAD.2015.08.007; Lyu H.-L., Cao J.-X., Wang H.-Y. et al. Differentiation between pancreatic metastases from clear cell renal cell carcinoma and pancreatic neuroendocrine tumor using double-echo chemical shift imaging. Abdom. Radiol. 2018; 43 (10): 2712–2720. https://doi.org/10.1007/s00261-018-1539-7; Ambrosetti M.C., Zamboni G.A., Fighera A., Mansueto G. Pancreatic metastases from renal neoplasms and neuroendocrine pancreatic tumours: is a differential diagnosis possible with CT? Hell. J. of Radiol. 2019; 4 (3). 17–21. https://doi.org/10.36162/HJR.V4I3.295; https://medvis.vidar.ru/jour/article/view/1279
-
13Academic Journal
Συγγραφείς: Lyubimova N.V., Timofeev Y.S., Lebedeva A.V., Kushlinskii N.E.
Πηγή: Advances in Molecular Oncology; Vol 8, No 3 (2021); 8-13 ; Успехи молекулярной онкологии; Vol 8, No 3 (2021); 8-13 ; 2413-3787 ; 2313-805X
Θεματικοί όροι: chromogranin A, chromogranin B, biochemical marker, neuroendocrine tumors, diagnosis, хромогранин А, хромогранин В, биохимический маркер, нейроэндокринная опухоль, диагностика
Περιγραφή αρχείου: application/pdf
Relation: https://umo.abvpress.ru/jour/article/view/375/235; https://umo.abvpress.ru/jour/article/view/375
-
14Academic Journal
Συγγραφείς: K. A. Romanova, A. B. Lukianchenko, B. M. Medvedeva, A. N. Polyakov, К. А. Романова, А. Б. Лукьянченко, Б. М. Медведева, А. Н. Поляков
Πηγή: Medical Visualization; Том 25, № 3 (2021); 43-49 ; Медицинская визуализация; Том 25, № 3 (2021); 43-49 ; 2408-9516 ; 1607-0763
Θεματικοί όροι: МРТ, mucinous tumor, intraductal papillary mucinous neoplasm, IPMN, neuroendocrine tumor, NET, CT, MRI, муцинозная опухоль, нейроэндокринная опухоль, КТ
Περιγραφή αρχείου: application/pdf
Relation: https://medvis.vidar.ru/jour/article/view/1030/670; https://medvis.vidar.ru/jour/article/downloadSuppFile/1030/1189; https://medvis.vidar.ru/jour/article/downloadSuppFile/1030/1190; https://medvis.vidar.ru/jour/article/downloadSuppFile/1030/1191; https://medvis.vidar.ru/jour/article/downloadSuppFile/1030/1251; WHO classification of tumours. 5th ed. Digestive system tumours edited by the WHO Classification of Tumours Editorial Board. Lyon, IARC Press, 2019.; Demos T.C., Posniak H.V., Harmath C., Olson M.C., Aranha G. Cystic Lesions of the Pancreas. Am J. Roentgenol. 2002; 179: 1375–1388. https://doi.org/10.2214/ajr.179.6.1791375; Sahani D.V., Kambadakone A., Macari M., Takahashi N., Chari S., Fernandez-del Castillo C. Diagnosis and Management of Cystic Pancreatic Lesions. Am J. Roentgenol. 2013; 200: 343–354. https://doi.org/10.2214/ajr.12.8862; Adsay N.V. Cystic neoplasia of the pancreas: pathology and biology. J. Gastrointest. Surg. 2008; 12 (3): 401–404. https://doi.org/10.1007/s11605-007-0348-z; Wang Yi., Miller F.H., Chen Z.E., Merrick L., Mortele K.J., Hoff F.L., Hammond N.A., Yaghmai V., Nikolaidis P. Diffusion-weighted MR Imaging of Solid and Cystic Lesions of the Pancreas. RadioGraphics. 2011; 31: 47–65. https://doi.org/10.1148/rg.313105174; Kucera J.N., Kucera S., Perrin S.D., Caracciolo J.T., Scmulewitz N., Kedar R.P. Cystic Lesions of the Pancreas: Radiologic-Endosonographic Correlation. RadioGraphics. 2012; 32: 283–301. https://doi.org/10.1148/rg.327125019; Salvia R., Fernández-del Castillo C., Bassi C., Thayer S.P., Falconi M., Matovania W., Pederzoli P., Warshaw A.L. Main-duct intraductal papillary mucinous neoplasms of the pancreas: Clinical predictors of malignancy and longterm survival following resection. Ann. Surg. 2004; 239: 678–687. https://doi.org/10.1097/01.sla.0000124386.54496.15; Tanaka M., Fernandez-del Castello C., Adsay V., Chari S., Falconi M., Jang J.Y., Kimura W., Levy P., Pitman M.B., Schmidt C.M., Shimizu M., Wolfgang C.L., Yamaguchi K., Yamao K. International Association of Pancreatology. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology. 2012; 12: 183–197. https://doi.org/10.1016/j.pan.2012.04.004; Hwang D.W., Jang J.Y., Lee S.E., Lim C.S., Lee K.U., Kim S.W. Clinicopathologic analysis of surgically proven intraductal papillary mucinous neoplasms of the pancreas in SNUH: A 15-year experience at a single academic institution. Langenbecks Arch. Surg. 2012; 397: 93–102. https://doi.org/10.1007/s00423-010-0674-6.; Лукьянченко А.Б., Романова К.А. Современная тактика распознавания новообразований поджелудочной железы. М., 2018. 112 с.; Machado N.O., al Qadhi H., al Wahibi K. Intraductal Papillary Mucinous Neoplasm of Pancreas. N. Am. J. Med. Sci. 2015; 7 (5): 160–175. https://doi.org/10.4103/1947-2714.157477; Jeurnink S.M., Vleggaar F.P., Siersema P.D. Overview of the clinical problem: Facts and current issues of mucinous cystic neoplasms of the pancreas. Dig. Liver Dis. 2008; 40: 837–46. https://doi.org/10.1016/j.dld.2008.03.018; Gupta R., Mortelé K.J., Tatli S., Girshman J., Glickman J.N., Levy A.D., Erturk S.M., Heffess C.S., Banks P.A, Stuart G. Pancreatic intraductal mucinous neoplasms: Role of CT in predicting pathologic subtypes. Am J. Roentgenol. 2008; 191: 1458–1464. https://doi.org/10.2214/ajr.07.3302; Tan E.H. Imaging of gastroenteropancreatic neuroendocrine tumors. Wld J. Clin. Oncol. 2011; 2 (1): 28–43. https://doi.org/10.5306/wjco.v2.i1.28; Oberg K. Pancreatic endocrine tumors. Sem. Oncol. 2010; 37 (6): 594–618. https://doi.org/10.1053/j.seminoncol.2010.10.014; Noone T.C., Hosey J., Firat Z., Semelka R.C. Imaging and localization of islet-cell tumours of the pancreas on CT and MRI. Best Pract. Res. Clin. Endocrinol. Metab. 2005; 19 (2): 195–211. https://doi.org/10.1016/j.beem.2004.11.013; Степанова Ю.А., Дубова Е.А., Кармазановский Г.Г., Сидорова Е.Е., Икрамов Р.З. Лучевая диагностика нейроэндокринных опухолей поджелудочной железы с кистозной трансформацией структуры. Медицинская визуализация. 2009; 4: 98–109.; Ishida M., Shiomi H., Naka S., Tani T., Okabe H. Concomitant intraductal papillary mucinous neoplasm and neuroendocrine tumor of the pancreas. Oncol. Lett. 2013; 5: 63–67 (In Japan).; Vazquez A.M., Ramia J.M., Lattore-Fragua R., ValleRubio A., Arteaga-Peralta V., Ramiro-Perez C., PlazaLlamas R.P. Pancreatic Neuroendocrine Tumors and Intraductal Papillary Mucinous Neoplasm of the Pancreas: A Systematic Review. Pancreas. 2018; 47 (5): 551–555. https://doi.org/10.1097/mpa.0000000000001048; https://medvis.vidar.ru/jour/article/view/1030
-
15Academic Journal
Συγγραφείς: O. Kit I., V. Trifanov S., N. Timoshkina N., E. Kolesnikov N., D. Gvaldin Y., N. Karnaukhov S., D. Kutilin S., M. Meshcheryakova Y., О. Кит И., В. Трифанов С., Н. Тимошкина Н., Е. Колесников Н., Д. Гвалдин Ю., Н. Карнаухов С., Д. Кутилин С., М. Мещерякова Ю.
Πηγή: Bulletin of Siberian Medicine; Том 20, № 2 (2021); 233-238 ; Бюллетень сибирской медицины; Том 20, № 2 (2021); 233-238 ; 1819-3684 ; 1682-0363 ; 10.20538/1682-0363-2021-20-2
Θεματικοί όροι: neuroendocrine tumor, Zollinger – Ellison syndrome, next generation sequencing, metastases, нейроэндокринная опухоль, синдром Золлингера – Эллисона, секвенирование нового поколения, метастазы
Περιγραφή αρχείου: application/pdf
Relation: https://bulletin.tomsk.ru/jour/article/view/4402/3007; https://bulletin.tomsk.ru/jour/article/view/4402/3037; Ellison E.C., Johnson J.A. The Zollinger – Ellison syndrome: A comprehensive review of historical, scientific, and clinical considerations. Curr. Probl. Surg. 2009; 46 (1): 13–106. DOI:10.1067/j.cpsurg.2008.09.001.; Shao Q., Zhao B., Dong L., Cao H., Wang H. Surgical management of Zollinger – Ellison syndrome: Classical considerations and current controversies. World J. Gastroenterol. 2019; 25 (32): 4673–4681. DOI:10.3748/wjg.v25.i32.4673.; Ito T., Cadiot G., Jensen R.T. Diagnosis of Zollinger – Ellison syndrome: Increasingly difficult. World J. Gastroenterol. 2012; 18 (39): 5495–5503. DOI:10.3748/wjg.v18.i39.5495.; Stevenson M., Lines K.E., Thakker R.V. Molecular Genetic Studies of Pancreatic Neuroendocrine Tumors: New Therapeutic Approaches. Endocrinol. Metab. Clin. N. Am. 2018; 47 (3): 525–548. DOI:10.1016/j.ecl.2018.04.007.; Albers M.B., Manoharan J., Bartsch D.K. Contemporary surgical management of the Zollinger – Ellison syndrome in multiple endocrine neoplasia type 1. Best Pract. Res. Clin. Endocrinol. Metab. 2019; 33 (5): 101–318. DOI:10.1016/j.beem.2019.101318.; Norton J.A., Foster D.S., Ito T., Jensen R.T. Gastrinomas. Medical or surgical treatment. Endocrinol. Metab. Clin. N. Am. 2018; 47 (3): 577–601. DOI:10.1016/j.ecl.2018.04.009.; Schwarzkopf G., Pfisterer J. Metastasizing gastrinoma and tuberous sclerosis complex. Association or coincidence? Zentralbl. Pathol. 1994; 139 (6): 477–481.; Li M.M., Datto M., Duncavage E.J., Kulkarni S., Lindeman N.I., Roy S., Tsimberidou A.M., Vnencak-Jones C.L., Wolff D.J., Younes A., Nikiforova M.N. Standards and guidelines for the interpretation and reporting of sequence variants in cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists. J. Mol. Diagn. 2017; 19 (1): 4–23. DOI:10.1016/j.jmoldx.2016.10.002.; Gleeson F.C., Voss J.S., Kipp B.R., Kerr S.E., van Arnam J.S., Mills J.R., Marcou C.A., Schneider A.R., Tu Z.J., Henry M.R., Levy M.J. Assessment of pancreatic neuroendocrine tumor cytologic genotype diversity to guide personalized medicine using a custom gastroenteropancreatic next-generation sequencing panel. Oncotarget. 2017; 8 (55): 93464–93475. DOI:10.18632/oncotarget.18750.; Jiao Y., Yonescu R., Offerhaus G.J., Klimstra D.S., Maitra A., Eshleman J.R., Herman J.G., Poh W., Pelosof L., Wolfgang C.L., Vogelstein B., Kinzler K.W., Hruban R.H., Papadopoulos N., Wood L.D. Whole-exome sequencing of pancreatic neoplasms with acinar differentiation. J. Pathol. 2014; 232 (4): 428–435. DOI:10.1002/path.4310.; Niida Y., Wakisaka A., Tsuji T., Yamada H., Kuroda M., Mitani Y., Okumura A., Yokoi A. Mutational analysis of TSC1 and TSC2 in Japanese patients with tuberous sclerosis complex revealed higher incidence of TSC1 patients than previously reported. J. Hum. Genet. 2013; 58 (4): 216–225. DOI:10.1038/jhg.2013.3.; https://bulletin.tomsk.ru/jour/article/view/4402
-
16Academic Journal
Συγγραφείς: K. V. Menshikov, A. V. Sultanbaev, Sh. I. Musin, I. A. Menshikova, A. F. Nasretdinov, N. I. Sultanbaeva, I. R. Shaykhutdinov
Πηγή: Креативная хирургия и онкология, Vol 11, Iss 2, Pp 174-182 (2021)
Θεματικοί όροι: нейроэндокринная опухоль, карциноид, карциноидный синдром, аналоги соматостатина, классификация опухолей, Surgery, RD1-811, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
Relation: https://www.surgonco.ru/jour/article/view/588; https://doaj.org/toc/2307-0501; https://doaj.org/toc/2076-3093; https://doaj.org/article/9d96be37f5e4432488cd8ab75a7b2ba0
-
17Academic Journal
Συγγραφείς: I. N. Peregorodiev, S. V. Vinokurova, V. Yu. Bohyan, V. V. Delektorskaya, O. A. Malikhova, V. A. Gorbunova, B. I. Sakibov, D. S. Elkin, I. S. Stilidi, И. Н. Перегородиев, С. В. Винокурова, В. Ю. Бохян, В. В. Делекторская, О. А. Малихова, В. А. Горбунова, Б. И. Сакибов, Д. С. Елкин, И. С. Стилиди
Πηγή: Advances in Molecular Oncology; Том 7, № 3 (2020); 19–26 ; Успехи молекулярной онкологии; Том 7, № 3 (2020); 19–26 ; 2413-3787 ; 2313-805X ; 10.17650/2313-805X-2020-7-3
Θεματικοί όροι: нейроэндокринная опухоль желудка, neuroendocrine tumor of stomach
Περιγραφή αρχείου: application/pdf
Relation: https://umo.abvpress.ru/jour/article/view/283/208; Frilling A., Modlin I.M., Kidd M. et al. Recommendations for management of patients with neuroendocrine liver metastases. Lancet Oncol 2014;15(1):e8–21. DOI:10.1016/S1470-2045(13)70362-0.; Okita N.T., Kato K., Takahari D. et al. Neuroendocrine tumors of the stomach: chemotherapy with cisplatin plus irinotecan is effective for gastric poorlydifferentiated neuroendocrine carcinoma.a Gastric Cancer 2011;14(2):161–5. DOI:10.1007/s10120-011-0025-5.; Lee R.C., Feinbaum R.L., Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993;75:843–54. DOI:10.1016/0092-8674(93)90529-y.; http://www.mirbase.org/.; Valencia-Sanchez M.A., Liu J., Hannon G.J., Parker R. Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev 2006;20(5):515–24. DOI:10.1101/gad.1399806.; Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116(2):281–97. DOI:10.1016/s0092-8674(04)00045-5.; Friedman R.C., Kai-How Farh K., Burge C.B., Bartel D.P. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009;19(1):92–105. DOI:10.1101/gr.082701.108.; Lewis B.P., Burge C.B., Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005;120:15–20. DOI:10.1016/j.cell.2004.12.035.; Harfe B.D. MicroRNAs in vertebrate development. Curr Opin Genet Dev 2005; 15:410–5. DOI:10.1016/j.gde.2005.06.012.; Croce C.M. Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 2009;10:704–14. DOI:10.1038/nrg2634.; Zhang B., Pan X., Cobb G.P. et al. microRNAs as oncogenes and tumor suppressors. Dev Biol 2007;302:1–12. DOI:10.1016/j.ydbio.2006.08.028.; Calin G.A., Sevignani C., Dumitru C.D. et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 2004;101:2999–3004. DOI:10.1073/pnas.0307323101.; Calin G.A., Dumitru C.D., Shimizu M. et al. Frequent deletions and downregulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2002;99(24):15524–9. DOI:10.1073/pnas.242606799.; Cimmino A., Calin G.A., Fabbri M. et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA 2005;102(39):13944–9. DOI:10.1073/pnas.0506654102.; Lu J., Getz G., Miska E.A. et al. MicroRNA expression profiles classify human cancers. Nature 2005;435(7043):834–8. DOI:10.1038/nature03702.; Hiyoshi Y., Watanabe M. MicroRNAs in gastrointestinal cancer: a novel biomarker and its clinical application. J Cancer Metastasis Treat 2015;1:144–55.; Di Leva G., Croce C.M. miRNA profiling of cancer. Curr Opin Genet Dev 2013; 23:3–11. DOI:10.1016/j.gde.2013.01.004.; Chen X., Ba Y., Ma L. et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008;18(10):997–1006. DOI:10.1038/cr.2008.282.; Basak I., Patil K.S., Alves G. et al. MicroRNAs as neuroregulators, biomarkers and therapeutic agents in neurodegenerative diseases. Cell Mol Life Sci 2016;73(4):811–27. DOI:10.1007/s00018-015-2093-x.; Kosaka N., Iguchi H., Ochiya T. Circulating 23 microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Cancer Sci 2010;101:2087–92. DOI:10.1111/j.1349-7006.2010.01650.x.; Vazquez-Martinez R., Gasman S. The regulated secretory pathway in neuroendocrine cells. Front Endocrinol (Lausanne) 2014;5:48. DOI:10.3389/fendo.2014.00048.; Thorns C., Schurmann C., Gebauer N. et al. Global microRNA profiling of pancreatic neuroendocrine neoplasias. Anticancer Res 2014;34(5):2249–54.; Singh R., Ramasubramanian B., Kanji S. et al. Circulating microRNAs in cancer: hope or hype? Cancer Lett 2016;381(1): 113–21. DOI:10.1016/j.canlet.2016.07.002.; Mittelbrunn M., Gutiérrez-Vázquez C., Villarroya-Beltri C. et al. Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells. Nat Commun 2011;2:282. DOI:10.1038/ncomms1285.; Sperveslage J., Hoffmeister M., Henopp T. et al. Establishment of robust controls for the normalization of miRNA expression in neuroendocrine tumors of the ileum and pancreas. Endocrine 2014;46(2):226–30. DOI:10.1007/s12020-014-0202-5.; Roldo C., Missiaglia E., Hagan J.P. et al. MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J Clin Oncol 2006;24:4677–84. DOI:10.1200/JCO.2005.05.5194.; Li S.C., Essaghir A., Martijn C. et al. Global microRNA profiling of welldifferentiated small intestinal neuroendocrine tumors. Mod Pathol 2013;26:685–96. DOI:10.1038/modpathol.2012.216.; Liang L., Zheng X., Hu M. et al. MiRNA-221/222 in thyroid cancer: a meta-analysis. Clin Chim Acta 2018;484:284–92. DOI:10.1016/j.cca.2018.06.012.; Hetta H.F., Zahran A.M., El-Mahdy R.I. et al. Assessment of circulating miRNA-17 and miRNA-222 expression profiles as non-invasive biomarkers in egyptian patients with non-small-cell lung. Cancer Asian Pac J Cancer Prev 2019;20(6):1927–33. DOI:10.31557/APJCP.2019.20.6.1927.; Li Y., Di C., Li W. et al. Oncomirs miRNA-221/222 and tumor suppressors miRNA-199a/195 are crucial miRNAs in liver cancer: a systematic analysis. Dig Dis Sci 2016;61(8):2315–27. DOI:10.1007/s10620-016-4156-8.; Ke S.B., Qiu H., Chen J.M. et al. MicroRNA-202-5p functions as a tumor suppressor in colorectal carcinoma by directly targeting SMARCC1. Gene 2018;676:329–35. DOI:10.1016/j.gene.2018.08.064.; Lloyd K.A., Moore A.R., Parsons B.N. et al. Gastrin-induced miR-222 promotes gastric tumor development by suppressing p27KIP1. Oncotarget 2016;7(29):45462–78. DOI:10.18632/oncotarget.9990.; Dockray G., Dimaline R., Varro A. Gastrin: old hormone, new functions. Pflugers Arch 2005;449:344–55. DOI:10.1007/s00424-004-1347-5.; Le Sage C., Nagel R., Egan D.A. et al. Regulation of the p27 (KIP1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. EMBO J 2007;26:3699–708. DOI:10.1038/sj.emboj.7601790.; Byun S.W., Chang Y.J., Chung I.S. et al. Helicobacter pylori decreases p27 expression through the delta opioid receptor-mediated inhibition of histone acetylation within the p27 promoter. Cancer Lett 2012;326:96–104. DOI:10.1016/j.canlet.2012.07.032.; Shu-Ping L., Xue-Jun C., Ai-Hua S. et al. CagA + H. pylori induces Akt1 phosphorylation and inhibits transcription of p21 WAF1/CIP1 and p27KIP1 via PI3K/ Akt1 pathway. Biomed Environ Sci 2010;23:273–8. DOI:10.1016/S0895-3988(10)60063-3.; Wen S., So Y., Singh K. et al. Promotion of cytoplasmic mislocalization of p27 by Helicobacter pylori in gastric cancer. Oncogene 2012;31:1771–80. DOI:10.1038/onc.2011.362.; Eguchi H., Herschenhous N., Kuzushita N., Moss S.F. Helicobacter pylori increases proteasome-mediated degradation of p27 (KIP1) in gastric epithelial cells. Cancer Res 2003;63(15):4739–46.; Kuzushita N., Rogers A.B., Monti N.A. et al. p27KIP1 deficiency confers susceptibility to gastric carcinogenesis in Helicobacter pylori-infected mice. Gastroenterology 2005;129:1544–56. DOI:10.1053/j.gastro.2005.07.056.; Yu J., Leung W., Ng E. et al. Effect of Helicobacter pylori eradication on expression of cyclin D2 and p27 in gastric intestinal metaplasia. Aliment Pharmacol Ther 2001;15:1505–11. DOI:10.1046/j.1365-2036.2001.01038.x.; Peek R.M. Jr, Wirth H.P., Moss S.F. et al. Helicobacter pylori alters gastric epithelial cell cycle events and gastrin secretion in Mongolian gerbils. Gastroenterology 2000;118:48–59. DOI:10.1016/s0016-5085(00)70413-6.; Eguchi H., Carpentier S., Kim S. et al. p27KIP1 regulates the apoptotic response of gastric epithelial cells to Helicobacter pylori. Gut 2004;53:797–804. DOI:10.1136/gut.2003.032144.; Shirin H., Sordillo E.M., Kolevska T.K. et al. Chronic Helicobacter pylori infection induces an apoptosis-resistant phenotype associated with decreased expression of p27KIP1. Infect Immun 2000;68:5321–8. DOI:10.1128/iai.68.9.5321-5328.2000.; Sundaresan S., Kang A.J., Hayes M.M. et al. Deletion of Men1 and somatostatin induces hypergastrinemia and gastric carcinoids. Gut 2017;66(6):1012–21. DOI:10.1136/gutjnl-2015-310928.; Wander S.A., Zhao D., Slingerland J.M. p27: a barometer of signaling deregulation and potential predictor of response to targeted therapies. Clin Cancer Res 2011;17:12–8. DOI:10.1158/1078-0432.CCR-10-0752.; Dou D., Shi Y.F., Liu Q. et al. Hsa-miR- 202-3p, up-regulated in type 1 gastric neuroendocrine neoplasms, may target DUSP1. World J Gastroenterol 2018;24(5):573–82. DOI:10.3748/wjg.v24.i5.573.; Theodosiou A., Ashworth A. MAP kinase phosphatases. Genome Biol 2002;3(7):REVIEWS3009. DOI:10.1186/gb-2002-3-7-reviews3009.; Owens D.M., Keyse S.M. Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases. Oncogene 2007;26:3203–13. DOI:10.1038/sj.onc.1210412.; Shen J., Zhang Y., Yuc H. et al. Role of DUSP1/MKP1 in tumorigenesis, tumor progression and therapy. Cancer Med 2016;5:2061–8. DOI:10.1002/cam4.772.; https://umo.abvpress.ru/jour/article/view/283
-
18Academic Journal
Συγγραφείς: Trifanov V.S., Maksimov A.Y., Goncharova A.S., Lukbanova E.A., Karnaukhov N.S., Kit S.O., Volkova A.V., Protasova T.P., Tkachev S.Y., Khodakova D.V., Zaikina E.V., Mindar M.V., Akulshina I.M.
Πηγή: Almanac of Clinical Medicine; Vol 48, No 2 (2020); 117-124 ; Альманах клинической медицины; Vol 48, No 2 (2020); 117-124 ; 2587-9294 ; 2072-0505
Θεματικοί όροι: pancreatic neuroendocrine tumor (pNET), orthotopic PDX model, immunodeficient mice, xenograft, transplantation, высокодифференцированная нейроэндокринная опухоль поджелудочной железы, ортотопическая PDX-модель, иммунодефицитные мыши, ксенографт, трансплантация
Περιγραφή αρχείου: application/pdf
Relation: https://almclinmed.ru/jour/article/view/1323/1205; https://almclinmed.ru/jour/article/downloadSuppFile/1323/2020; https://almclinmed.ru/jour/article/downloadSuppFile/1323/2021; https://almclinmed.ru/jour/article/downloadSuppFile/1323/2022; https://almclinmed.ru/jour/article/downloadSuppFile/1323/2023; https://almclinmed.ru/jour/article/downloadSuppFile/1323/2024; https://almclinmed.ru/jour/article/downloadSuppFile/1323/2025; https://almclinmed.ru/jour/article/downloadSuppFile/1323/2026; https://almclinmed.ru/jour/article/downloadSuppFile/1323/2027; https://almclinmed.ru/jour/article/downloadSuppFile/1323/2028; https://almclinmed.ru/jour/article/downloadSuppFile/1323/2029; https://almclinmed.ru/jour/article/view/1323
-
19Academic Journal
Πηγή: Вестник хирургии имени И.И. Грекова, Vol 172, Iss 2, Pp 060-062 (2018)
Θεματικοί όροι: нейроэндокринная опухоль поджелудочной железы, инсулинома, энуклеация опухоли, Surgery, RD1-811
Περιγραφή αρχείου: electronic resource
Σύνδεσμος πρόσβασης: https://doaj.org/article/9315672353e64e5984c554ccb1a558d4
-
20Academic Journal
Συγγραφείς: A. M. Ivanov, I. Ya. Skvortsov, V. V. Delektorskaya, V. A. Gorbunova, А. М. Иванов, И. Я. Скворцов, В. В. Делекторская, В. А. Горбунова
Πηγή: Cancer Urology; Том 15, № 1 (2019); 131-136 ; Онкоурология; Том 15, № 1 (2019); 131-136 ; 1996-1812 ; 1726-9776 ; 10.17650/1726-9776-2019-15-1
Θεματικοί όροι: мелкоклеточный рак предстательной железы, neuroendocrine tumor, small cell cancer of the prostate, нейроэндокринная опухоль
Περιγραφή αρχείου: application/pdf
Relation: https://oncourology.abvpress.ru/oncur/article/view/865/837; Small E.J., Huang J., Youngren J. et al. Characterization of neuroendocrine prostate cancer in patients with metastatic castration resistant prostate cancer resistant to abiraterone or enzalutamide: preliminary results from the SU2C/PCF/AACR West Coast Prostate Cancer Dream Team. J Clin Oncol 2015;33(suppl):abstr 5003.; Galanis E., Frytak S., Lloyd R.V. Extrapulmonary small cell carcinoma. Cancer 1997;79(9):1729 — 36. PMID: 9128989.; Helpap B., Kollermann J., Oehler U. Neuroendocrine differentiation in prostatic carcinomas: histogenesis, biology, clinical relevance, and future therapeutical perspectives. Urol Int 1999;62(3):133—8. DOI:10.1159/000030376. PMID: 10529661.; Wenk R.E., Bhagavan B.S., Levy R. et al. Ectopic ACTH, prostatic oat cell carcinoma, and marked hypernatremia. Cancer 1977;40(2):773-8. PMID: 196743.; Скворцов И.Я., Камолов Б.Ш., Хафизов К.О. и др. Нейроэндокринный рак предстательной железы (описание клинического случая). Онкоурология 2011;(2):92—5.; Oesterling J.E., Hauzeur C.G., Farrow G.M. Small cell anaplastic carcinoma of the prostate: a clinical, pathological and im-munohistological study of 27 patients. J Urol;147(3 Pt 2):804-7. PMID: 1311395.; Tetu B., Ro J.Y., Ayala A.G. et al. Small cell carcinoma of the prostate. Pt I. A clin-icopathologic study of 20 cases. Cancer 1987;59(10):1803—9. PMID: 3030528.; Palmgren J.S., Karavadia S.S., Wakefield M.R. Unusual and underappreciated: small cell carcinoma of the prostate. Semin Oncol 2007;34(1):22-9. DOI:10.1053/j.seminoncol.2006.10.026. PMID: 17270662.; Cristopher М.Е., Seftel A.D., Sorenson K., Resnick M.I. Small cell carcinoma of the genitourinary tract: an immunohistochem-ical, electron microscopic and clinico-pathological study. J Urol 1991;146(2):382—8. PMID: 1713277.; NCCN Clinical Practice Guidelines: Prostate Cancer. Version 1.2016.; Aparicio A.M., Harzstark A.L., Corn P.G. et al. Platinum-based chemotherapy for variant castrate-resistant prostate cancer. Clin Cancer Res 2013;19(13):3621-30. DOI:10.1158/1078-0432.CCR-12-3791. PMID: 23649003.; Aggarwal R., Huang J., Alumkal J.J. et al. Clinical and genomic characterization of treatment-emergent small-cell neuroendocrine prostate cancer: a multiinstitutional prospective study. Clin Oncol 2016;34(suppl 2S):abstr 288. DOI: org/10.1200/JCO.2017.77.6880.; https://oncourology.abvpress.ru/oncur/article/view/865